Joshua Linscott
Dr. Linscott received his PhD in Pharmacology from Weill Cornell Medical College, New York City. He received his MD degree at Tufts University School of Medicine, Boston, Massachusetts. Dr. Linscott completed a Urology Residency at Maine Medical Center, Portland, followed by Urologic Oncology fellowship at Moffitt Cancer Center, Tampa.
Dr. Linscott specializes in the treatment of patients with early and locally advanced bladder cancer, kidney cancer, and prostate cancer. He is a translational researcher focused on urothelial carcinoma, with a particular interest in the discovery and development of urinary cell-free DNA biomarkers. Dr. Linscott’s research goals include defining patterns of urinary cell-free DNA methylation as predictors of treatment response and disease progression, as well as studying the tumor immune microenvironment in BCG-treated patients using spatial transcriptomics.
2026 Sessions
Consolidation After Clinical Complete Response in Muscle-Invasive Bladder Cancer: Oncologic Necessity vs Outdated Over-treatment
This debate will focus on the optimal timing of cystectomy after achieving a clinical complete response, comparing immediate consolidation with surgery or radiation versus a...
-
Moderator
- Guru Sonpavde, MD
-
Presenter
- Arnab Basu, MD
- Joshua Linscott, MD, PhD